high prevalence of carbapenem-resistant A. baumannii carrying the bla OXA-143 and bla genes, along with the first isolation of strains carrying the bla OXA-72 (OXA-72 is a singleamino-acid variant of OXA-40) and bla OXA-58 genes in Brazilian hospitals.
From 2004 to 2008, 36 carbapenem-resistant A. baumannii isolates recovered from different patients hospitalized in eight medical centers were screened for the presence of genes encoding metallo-␤-lactamases (M␤Ls) and OXA-type ␤-lactamases (6, 15) . Flanking sequences of bla OXA -type genes were characterized by PCR using primers targeting ISAba-1 or -3 (12) . PCR products were confirmed by sequencing, and the e a All multidrug-resistant A. baumannii strains were included in this study. Multidrug resistance was defined as resistance to three or more representatives of the major antibiotic categories (i.e., quinolones, extended-spectrum cephalosporins, aminoglycosides, and carbapenems). The A. baumannii isolates were identified by using the Vitek 2 automated instrument ID system and conventional biochemical tests and by detection of the bla OXA-51 -like gene (10, 13) . Susceptibilities to all antimicrobial agents were determined by disk diffusion, agar dilution, and the Etest (AB Biodisk, Solna, Sweden) and interpreted according to criteria of the Clinical and Laboratory Standards Institute (3). ERIC-PCR fingerprint patterns were analyzed using the Dice similarity coefficient and the unweighted-pair group method using average linkages cluster method (BioNumeric software, Applied Maths, Kortrijk, Belgium genetic diversity of bla OXA -positive strains was determined by enterobacterial repetitive intergenic consensus (ERIC)-PCR analysis (11) . All isolates were found to be resistant to imipenem, meropenem, ceftazidime, aztreonam, piperacillin-tazobactam, and ciprofloxacin. Tobramycin (61.1%), ampicillin-sulbactam (61.1%), gentamicin (47.2%), amikacin (27.8%), and cefepime (11.1%) susceptibility rates were determined. M␤L-encoding genes were not identified, whereas a high prevalence of bla OXA genes was noticed among carbapenem-resistant isolates (Table 1) . In this regard, 21 strains (58.3%) carried the bla OXA-143 gene, 15 strains (41.7%) carried the ISAba-1/bla OXA-23 gene array, one strain carried the ISAba-3/bla OXA-58 /ISAba-3 gene array, and two isolates carried the bla OXA-72 gene (GenBank accession no. FJ628170, FJ492877, FJ969387, and HM804278 to HM804281). Although the presence of the bla OXA-51 and ISAba-1 genes was confirmed in all of the isolates, no colinearity of the two genes (i.e., ISAba-1 adjacent to the bla OXA-23 gene) was observed. Isolates harboring the bla OXA-143 , bla , and bla OXA-58 genes were restricted to hospitals located in São Paulo (the largest and most populous metropolitan area in southeastern Brazil), while bla OXA-23 -harboring A. baumannii isolates were obtained from hospitals in São Paulo and Paraná (in southern Brazil), confirming previous reports of widespread dissemination of OXA-23-producing A. baumannii in this region (2, 9) . Finally, ERIC-PCR typing revealed genetic diversity among bla OXA-143 -and bla OXA-23 -positive A. baumannii isolates.
In summary, the bla OXA-143 gene was commonly identified among the carbapenem-resistant A. baumannii isolates surveyed in this study. Also, we report the first isolation of bla OXA-72 -and bla OXA-58 -carrying strains in Brazilian hospitals. OXA-143 is a new subgroup of CHDL identified in isolates of A. baumannii from Brazil (5). We would only bring to mind that the bla OXA-72 gene was first reported from an A. baumannii strain in Thailand in 2004 (GenBank accession no. AY739646), and so far it has been restricted to Acinetobacter sp. isolates from Asian and Mediterranean countries (1, 4, 7, 8, 14) . 
